Alexandria Real Estate Equities, Inc.ARE
NYSE • Real Estate
$44.15
P/E
—
PEG
—
FCF Yield
—
Rev Growth YoY
-679.0% YoY
Gross Margin
7021.0%
Health Score
2/10
D/E Ratio
0.80
Confidence
LOW
Business Snapshot
Alexandria Real Estate Equities (ARE) is a REIT specialising in life science and technology office campuses, primarily serving pharmaceutical, biotech, and research-focused tenants across major U.S. innovation clusters. The stock currently trades at $44.15, having fallen sharply from its 52-week high of $88.24 — a decline of approximately 50%. Based on available pricing and ratio data, the company appears to fall within the mid-to-large cap tier, though a precise market cap figure is not available in this dataset.
Financial Health
Score: 2/10 The financial picture is deeply concerning across multiple dimensions. The net margin stands at an alarming -4,743%, indicating severe losses relative to revenue — a figure that, even accounting for REIT-specific accounting conventions, signals fundamental stress...
Risk Assessment
- **DATA VACUUM:** P/E ratio, TTM revenue, and free cash flow are all unavailable, making comprehensive fundamental analysis impossible and significantly elevating investment risk. - **REVENUE COLLAPSE:** Revenue growth of -679.0% year-over-year indicates extreme top-line deterioration, whether from asset sales, impairments, or operational disruption. - **LIQUIDITY:** Current ratio of 0.28x is well below the 1.0x threshold typically considered the minimum for short-term financial stability. - **RETURNS:** Return on equity of -857% paired with a net margin of -4,743% indicates the company is destroying shareholder value at a severe rate. - **TECHNICALS & PRICE:** The stock is in a death cross pattern (50-day MA crossing below 200-day MA), with MACD bearish — confirming sustained downward price momentum from the $88.24 52-week high....